About this trial
Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis
Eligibility criteria
Qualifiers
◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.
FIGO 2014 stage IA-IVB.
Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
Patients with no residual disease after surgery.
Disqualifiers
◦ Patients without epithelial ovarian cancer.
Patients with ECOG 2-4.
Patients who do not consent to participate in the study.
Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.
Trial design
Treatments tested in this trial
- resection of infundibulopelvic ligament